Cadent Capital Advisors LLC Buys New Shares in Astera Labs, Inc. $ALAB

Cadent Capital Advisors LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,182 shares of the company’s stock, valued at approximately $1,845,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Reflection Asset Management purchased a new stake in shares of Astera Labs in the fourth quarter valued at $25,000. Keating Financial Advisory Services Inc. purchased a new position in shares of Astera Labs during the second quarter valued at $25,000. Archer Investment Corp purchased a new stake in Astera Labs in the 2nd quarter worth about $30,000. Whipplewood Advisors LLC boosted its position in Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the period. Finally, Transamerica Financial Advisors LLC acquired a new position in shares of Astera Labs in the 2nd quarter valued at about $35,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Aries 7 expands Astera’s AI connectivity opportunity. Astera introduced what it describes as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and transimpedance amplifiers designed for next-generation AI systems. Astera Labs Announces Aries 7
• Positive Sentiment: The product launch strengthens Astera’s competitive positioning. Analysts view Aries 7 as an expansion of Astera’s PCIe portfolio and an effort to compete more directly with Marvell Technology and Credo Technology as hyperscalers increase spending on AI servers and high-speed data movement. ALAB Expands PCIe Portfolio With Aries 7
• Positive Sentiment: Broader optimism about AI-chip connectivity previously lifted ALAB. Marvell’s projection that chip-connectivity could become a roughly $37 billion annual business by fiscal 2031 helped boost related semiconductor and optical-networking stocks, including Astera. Astera’s latest quarter also showed strong fundamentals, with revenue up 104.5% year over year and earnings exceeding consensus estimates.
• Neutral Sentiment: Astera is increasingly viewed as an optical-infrastructure company. Its move across copper and optical links could increase its addressable market as AI clusters scale, but the company must demonstrate that the new products translate into sustained revenue and customer adoption. Astera Labs becomes an optical stock
• Negative Sentiment: Valuation and concentration risks remain significant. ALAB trades at a very high earnings multiple, while Amazon Web Services reportedly represents about 70% of revenue. That dependence could magnify downside if a major customer slows AI infrastructure investment or shifts to competing solutions.
• Negative Sentiment: Northland Securities downgraded the stock from “outperform” to “market perform.” The downgrade reinforces concerns that substantial growth expectations are already reflected in the share price, particularly after the stock’s large 2026 advance.

Insider Transactions at Astera Labs

In other news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief executive officer owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 396,059 shares of company stock worth $122,605,660. Insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ ALAB traded down $6.13 during trading hours on Friday, hitting $340.92. 2,534,466 shares of the stock were exchanged, compared to its average volume of 5,183,139. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The company’s 50 day moving average is $316.82 and its 200 day moving average is $290.03. The firm has a market capitalization of $59.14 billion, a P/E ratio of 168.92 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Bank of America boosted their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. UBS Group reissued a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Roth Capital reiterated a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Barclays boosted their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Ten research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Hold” and an average price target of $348.33.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.